Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models
Publication date
2020
Authors
Weaver, Richard J
Blomme, Eric A
Chadwick, Amy E
Copple, Ian M
Gerets, Helga H J
Goldring, Christopher E
Guillouzo, Andre
Hewitt, Philip G
Ingelman-Sundberg, Magnus
Jensen, Klaus Gjervig
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Drug-induced liver injury (DILI) is a patient-specific, temporal, multifactorial pathophysiological process that cannot yet be recapitulated in a single in vitro model. Current preclinical testing regimes for the detection of human DILI thus remain inadequate. A systematic and concerted research effort is required to address the deficiencies in current models and to present a defined approach towards the development of new or adapted model systems for DILI prediction. This Perspective defines the current status of available models and the mechanistic understanding of DILI, and proposes our vision of a roadmap for the development of predictive preclinical models of human DILI.
Keywords
Taverne
Citation
Weaver, R J, Blomme, E A, Chadwick, A E, Copple, I M, Gerets, H H J, Goldring, C E, Guillouzo, A, Hewitt, P G, Ingelman-Sundberg, M, Jensen, K G, Juhila, S, Klingmüller, U, Labbe, G, Liguori, M J, Lovatt, C A, Morgan, P, Naisbitt, D J, Pieters, R H H, Snoeys, J, van de Water, B, Williams, D P & Park, B K 2020, 'Managing the challenge of drug-induced liver injury : a roadmap for the development and deployment of preclinical predictive models', Nature Reviews. Drug Discovery, vol. 19, pp. 131–148. https://doi.org/10.1038/s41573-019-0048-x